Professional Documents
Culture Documents
Questions
Results
Shape-based differences
Radial Distance
Volumetric differences
Jacobian Determinant
Accumbens
-4
-4
2
4 p = 0.15
= 37
p = 0.65
= 27
Accumbens
0
-3
0
-3
p = 0.15
= 76
p = 0.019
= 440
p = 0.075
= 270
Control
Illness Duration
Illness Duration
3rd Ventricle
p = 0.97
= 0.22
p = 0.97
= 0.58
p = 0.97
= 0.37
p = 0.97
= 5.5
p = 0.97
= 0.19
400
p = 0.97
= 0.072
400
Amygdala
p = 0.74
= 3.5
400
Brain Stem
Caudate
p = 0.54
= 13
400
Callosum
400
400
400
400
Pallidum
p = 0.54
= 6.3
Putamen
p = 0.88
= 6.2
400
400
400
3rd Ventricle
Thalamus
p = 0.88
= 2.9
p = 0.97
= 0.61
p = 0.97
= 0.032
p = 0.74
= 36
p = 0.88
= 5.5
2
4 p = 0.7
p = 0.91
= 0.66
= 2.3
p = 0.88
= 3.7
30
Amygdala
p = 0.84
= 73
30
Brain Stem
30
Caudate
p = 0.9
= 23
30
p = 0.54
= 14
Callosum
Hippocampus
p = 0.84
= 210
30
30
30
Lat. Ventricle
p = 0.9
= 1000
Pallidum
p = 0.9
= 20
30
Putamen
p = 0.84
= 210
p = 0.88
=5
p = 0.84
= 610
30 0
Thalamus
30
3rd Ventricle
p = 0.9
= 84
p = 0.9
= 40
p = 0.9
= 29
p = 0.9
= 16
p = 0.84
= 160
p = 0.84
= 150
p = 0.9
= 590
p = 0.9
= 7.9
p = 0.9
= 78
p = 0.9
= 73
Viral Load
Combined-Metric Models
p = 0.35
= 9.6
4 p = 0.84
= 34
-4
Classification performance
by descriptor
p = 0.54
= 220
-5
30
p = 0.54
= 15
p = 0.74
= 8.7
Accumbens
Thalamus
p = 0.97
= 0.024
Undetectable
Right
t-value
T-value maps of the subcortical surfaces modeling shape differences between HIV+ and control cohorts. First and third
columns illustrate raw t-values from the main effect's coefficient. Second and fourth columns show thresholded surfaces
in which regions not significantly different following FDR correction are depicted in black.
Putamen
p = 0.97
= 0.19
Midline
4 p = 0.9
= 11
Viral Load
Viral Load
-4
= 0.23
= 7.8
= 0.037
HIV+
Left
0
-4
Callosum
Right
t-value
Radial Distance
Detectable
100
Conclusions
Using volumetric and shape-based descriptors we were able to characterize
abnormal subcortical morphometry in HIV.
80
Correctly predicted that more extreme clinical measures were associated with
more extreme subcortical atrophy.
Sensitivity (%)
60
40
20
Class Prediction
p = 0.044
= 3900
Midline
Caudate
p = 0.97
= 0.38
p = 0.97
= 0.1
= 0.012
Brain Stem
Left
0
-3
0
-2
AUC
Model
100
80
60
40
20
0 100
Specificity (%)
AUC
Right
Email: Benjamin.SC.Wade@gmail.com
4 p = 0.97
p(c|v) = 1T pt (c|v)
Single-Metric Models
U
4) Class prediction
based on vote of
terminal nodes
= 0.64
Radial Distance
...
Accumbens
3) Nodes split by
features maximizing
class purity
2) Sub-tree input
is a bootstrapped
set of observations
and a random
subset of features
v1
p = 0.97
= 0.58
vt
Midline
p = 0.089
= 210
1) RF intput is the
set of all features
4 p = 0.88
3rd Ventricle
Left
3) Compute
shape metrics at
each vertex
Thalamus
p = 0.019
= 390
Jacobian Determinant
p = 0.89
= 14
Amygdala
p = 0.97
= 0.0082
= 0.11
14
Putamen
p = 0.044
= 330
p = 0.0079
= 420
4 p = 0.97
Subjects
63 elderly HIV+ subjects: 65.35 years old, 4 women
d)
Pallidum
p = 0.0079
= 180
HIV Status
2) Create mesh
surface for each c)
region
b)
Lat. Ventricle
p = 0.019
= 5100
p = 0.02
= 290
1) Segment sub- a)
cortical regions
using FreeSurfer
Morphometric descriptors
Hippocampus
p = 0.27
= 110
Methods
p = 0.15
= 770
Callosum
Caudate
p = 0.76
= 38
Right
HIV Status
Brain Stem
Midline
p = 0.76
= 19
Left
Introduction
Amygdala
4 p = 0.14
= 41
HIV Status
80
60
40
20
[1] L. Cysique, et al., "Prevalence and pattern of neuropsychological impairment in human immunodeficiency
virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active
antiretroviral therapy eras: A combined study of two cohorts," J. of NeuroVirology, vol. 10, pp. 350-357, 2004.
[2] Y. Wang , et al., "Applying tensor-based morphometry to parametric surfaces can improve MRI-based
disease diagnosis," NeuroImage, vol. 74, pp. 209-230, 2013.
[3] L. G. Apostolova, et al., 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment
and Alzheimer's disease vol. 129, 2006.
Acknowledgements: This work was supported in part by NIH 'Big Data to Knowledge' (BD2K) Center of
Excellence grant U54 EB020403, funded by a cross-NIH consortium including NIBIB and NCI and by the
National Science Foundation Graduate Research Fellowship under Grant No. DGE-0707424 and grant
numbers K23AG032872 (to V.V.), P50 AG023501 (ADRC, PI: Bruce Miller); P30-AI027763 (UCSF CFAR), UL1
RR024131 (UCSF GCRC), the Larry L. Hillblom Foundation and the AIDS Research Institute at UCSF.